Logo image of MRX

MAREX GROUP PLC (MRX) Stock Fundamental Analysis

NASDAQ:MRX - Nasdaq - GB00BMT7GT62 - Common Stock - Currency: USD

39.47  -0.54 (-1.35%)

After market: 39.6 +0.13 (+0.33%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MRX. MRX was compared to 233 industry peers in the Capital Markets industry. MRX has a bad profitability rating. Also its financial health evaluation is rather negative. MRX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MRX had positive earnings in the past year.
MRX had a positive operating cash flow in the past year.
MRX Yearly Net Income VS EBIT VS OCF VS FCFMRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

MRX has a worse Return On Assets (1.24%) than 63.52% of its industry peers.
The Return On Equity of MRX (30.81%) is better than 94.85% of its industry peers.
Industry RankSector Rank
ROA 1.24%
ROE 30.81%
ROIC N/A
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRX Yearly ROA, ROE, ROICMRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

MRX's Profit Margin of 9.43% is on the low side compared to the rest of the industry. MRX is outperformed by 62.23% of its industry peers.
In the last couple of years the Profit Margin of MRX has grown nicely.
MRX's Gross Margin of 39.71% is on the low side compared to the rest of the industry. MRX is outperformed by 66.09% of its industry peers.
MRX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 9.43%
GM 39.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
MRX Yearly Profit, Operating, Gross MarginsMRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

The number of shares outstanding for MRX has been increased compared to 1 year ago.
MRX has a better debt/assets ratio than last year.
MRX Yearly Shares OutstandingMRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
MRX Yearly Total Debt VS Total AssetsMRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.25, we must say that MRX is in the distress zone and has some risk of bankruptcy.
MRX's Altman-Z score of 0.25 is on the low side compared to the rest of the industry. MRX is outperformed by 72.10% of its industry peers.
The Debt to FCF ratio of MRX is 11.19, which is on the high side as it means it would take MRX, 11.19 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MRX (11.19) is comparable to the rest of the industry.
MRX has a Debt/Equity ratio of 10.92. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of MRX (10.92) is worse than 90.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 10.92
Debt/FCF 11.19
Altman-Z 0.25
ROIC/WACCN/A
WACCN/A
MRX Yearly LT Debt VS Equity VS FCFMRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.09 indicates that MRX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.09, MRX perfoms like the industry average, outperforming 48.50% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that MRX should not have too much problems paying its short term obligations.
MRX has a Quick ratio of 1.09. This is comparable to the rest of the industry: MRX outperforms 49.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
MRX Yearly Current Assets VS Current LiabilitesMRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5B 10B 15B 20B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.41% over the past year.
Measured over the past years, MRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.49% on average per year.
Looking at the last year, MRX shows a quite strong growth in Revenue. The Revenue has grown by 19.81% in the last year.
MRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.98% yearly.
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%

3.2 Future

The Earnings Per Share is expected to grow by 12.87% on average over the next years. This is quite good.
Based on estimates for the next years, MRX will show a quite strong growth in Revenue. The Revenue will grow by 10.70% on average per year.
EPS Next Y18%
EPS Next 2Y13.55%
EPS Next 3Y12.87%
EPS Next 5YN/A
Revenue Next Year16.02%
Revenue Next 2Y11.43%
Revenue Next 3Y10.7%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MRX Yearly Revenue VS EstimatesMRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
MRX Yearly EPS VS EstimatesMRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.92, the valuation of MRX can be described as very reasonable.
Based on the Price/Earnings ratio, MRX is valued a bit cheaper than the industry average as 72.96% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.15. MRX is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.13, which indicates a very decent valuation of MRX.
Based on the Price/Forward Earnings ratio, MRX is valued a bit cheaper than 64.38% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, MRX is valued a bit cheaper.
Industry RankSector Rank
PE 9.92
Fwd PE 11.13
MRX Price Earnings VS Forward Price EarningsMRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRX indicates a rather cheap valuation: MRX is cheaper than 87.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.46
EV/EBITDA N/A
MRX Per share dataMRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

MRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRX's earnings are expected to grow with 12.87% in the coming years.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y13.55%
EPS Next 3Y12.87%

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.41%, MRX has a reasonable but not impressive dividend return.
MRX's Dividend Yield is slightly below the industry average, which is at 8.00.
With a Dividend Yield of 1.41, MRX pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

MRX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
MRX Yearly Dividends per shareMRX Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y13.55%
EPS Next 3Y12.87%
MRX Yearly Income VS Free CF VS DividendMRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 200M 400M 600M 800M 1B

MAREX GROUP PLC

NASDAQ:MRX (6/30/2025, 8:00:01 PM)

After market: 39.6 +0.13 (+0.33%)

39.47

-0.54 (-1.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners47.54%
Inst Owner Change0%
Ins Owners6.62%
Ins Owner ChangeN/A
Market Cap2.81B
Analysts81.67
Price Target52.28 (32.46%)
Short Float %3.23%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date05-27 2025-05-27 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.61%
Min EPS beat(2)11.13%
Max EPS beat(2)18.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.52%
Min Revenue beat(2)2.3%
Max Revenue beat(2)8.73%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.82%
PT rev (3m)26.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.45%
EPS NY rev (1m)2.7%
EPS NY rev (3m)9.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.02%
Revenue NY rev (1m)1.9%
Revenue NY rev (3m)9.15%
Valuation
Industry RankSector Rank
PE 9.92
Fwd PE 11.13
P/S 0.88
P/FCF 2.46
P/OCF 2.42
P/B 2.88
P/tB 3.78
EV/EBITDA N/A
EPS(TTM)3.98
EY10.08%
EPS(NY)3.55
Fwd EY8.99%
FCF(TTM)16.06
FCFY40.68%
OCF(TTM)16.33
OCFY41.38%
SpS44.8
BVpS13.71
TBVpS10.44
PEG (NY)0.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 30.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 9.43%
GM 39.71%
FCFM 35.84%
ROA(3y)0.72%
ROA(5y)N/A
ROE(3y)16.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.13%
PM growth 5YN/A
GM growth 3Y-15.98%
GM growth 5YN/A
F-Score6
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 10.92
Debt/FCF 11.19
Debt/EBITDA N/A
Cap/Depr 69.1%
Cap/Sales 0.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 379.93%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.25
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.86%
Cap/Sales(5y)N/A
Profit Quality(3y)453.15%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.41%
EPS 3Y50.49%
EPS 5YN/A
EPS Q2Q%50.44%
EPS Next Y18%
EPS Next 2Y13.55%
EPS Next 3Y12.87%
EPS Next 5YN/A
Revenue 1Y (TTM)19.81%
Revenue growth 3Y36.98%
Revenue growth 5YN/A
Sales Q2Q%-76.39%
Revenue Next Year16.02%
Revenue Next 2Y11.43%
Revenue Next 3Y10.7%
Revenue Next 5YN/A
EBIT growth 1Y-18.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.58%
EBIT Next 3Y16.69%
EBIT Next 5YN/A
FCF growth 1Y58.2%
FCF growth 3Y35.13%
FCF growth 5YN/A
OCF growth 1Y58.3%
OCF growth 3Y35.2%
OCF growth 5YN/A